Dr. Granit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1150 NW 14th St
Ste 410
Miami, FL 33136Phone+1 305-243-3100Fax+1 305-243-8108
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, EMG, Neurmuscular Disorders, 2012 - 2013
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2012
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2008 - 2009
- Albert Einstein College of Medicine, Sue Golding GMS, Neuroscienece, 2004 - 2008
- Istanbul University FomClass of 2003
Certifications & Licensure
- FL State Medical License 2017 - 2025
- NY State Medical License 2012 - 2019
- American Board of Psychiatry and Neurology Neurology
- American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine
Clinical Trials
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 43 citationsSafety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-rand...Volkan Granit, Michael Benatar, Metin Kurtoglu, Miloš D Miljković, Nizar Chahin
The Lancet. Neurology. 2023-07-01 - 24 citationsAn International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.Sonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, Giovanni Antonini, Samuel Arends
Neurology. 2022-09-20 - 49 citationsPreventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.Michael Benatar, Joanne Wuu, Caroline A. McHutchison, Ronald B. Postuma, Bradley F. Boeve
Brain. 2021-10-22
Press Mentions
- Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia GravisMay 10th, 2022
- ALS Center at University of Miami Receives State Funding for Patient CareSeptember 25th, 2020
- Cartesian Initiates CAR-T Clinical Trial in Myasthenia GravisNovember 5th, 2019
Other Languages
- French, Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: